«Eczema

Below is an extended Eczema patents listing. Click here to return to the Eczema main in depth entry.

Patents :
US Patent No.	Title
7419677	Treatment device and method of using the same
7425418	Compounds that modulate processes associated with IgE production
7425447	Host cells expressing 7C10 and 16C10 CD80-specific antibodies
7425555	Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
7425610	Methods and materials relating to CD84-like polypeptides and polynucleotides
7425622	Antibodies against C3a receptor
7425637	N3 alkylated benzimidazole derivatives as MEK inhibitors
7427402	Method of evaluating inflammatory skin disorders using IL-17 and/or IL-19
7427403	Methods for inhibiting lymphotoxin .beta. receptor signalling
7427416	Methods of treating conditions using metal-containing materials
7427417	Aromatherapy delivery system
7425325	Cytokine zcytor17 ligand polypeptides
7423129	Antibodies to human eotaxin
7419958	Method of attenuating reactions to skin irritants
7419987	7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
7420055	Aryl sulfonamides
7420061	Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors
7422756	Skin preparation
7422764	Matrix-forming composition containing pectin
7422867	Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
7423042	Compounds
7423046	3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
7423049	Inhibitors of p38
7427471	Modified "S" antibodies
7427494	Nucleic acid encoding cytokine receptor zcytor17
7427606	Method to reduce inflammatory response in transplanted tissue
7432065	Methods of identifying modulators of interaction between PDZ domain proteins and PL proteins
7432101	Production of poxviruses with adherent or non adherent avian cell lines
7432257	Piperdinyl-phenoxazine and phenothiazine derivatives as .delta.-opioid modulators
7432266	Phosphodiesterase 4 inhibitors
7432277	Phosphorus-containing macrocycles
7432285	Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
7432289	5-Acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
7432290	Inhibitors of IMPDH enzyme
7432303	Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
7432308	Therapeutic compositions for the treatment of a respiratory tract disease
7431948	Compositions that treat or inhibit pathological conditions associated with inflammatory response
7429646	Antibodies to human tumor necrosis factor receptor-like 2
7427625	Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors
7427629	Immunostimulatory compositions and methods of stimulating an immune response
7427630	Condensed N-heterocyclic compounds and their use as CRF receptor antagonists
7427631	Metalloproteinase inhibitors
7427657	Aromatic sulfenates for type 1 phototherapy
7427685	Therapeutic substituted cyclopentanes
7429575	N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
7429596	1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
7429599	Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
7429609	Pyrazole compound and medicinal composition containing the same
7432369	Pyridyl-substituted porphyrin compounds and methods of use thereof

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.